Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.89 USD | -0.82% | +0.91% | -31.54% |
Mar. 26 | Enveric Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 19 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.54% | 6.55M | |
+3.14% | 43.43B | |
+47.81% | 41.69B | |
+7.93% | 41.31B | |
-10.92% | 27.14B | |
+8.08% | 25.28B | |
-24.49% | 18.47B | |
+29.16% | 12.59B | |
+0.92% | 12.33B | |
+8.94% | 11.03B |
- Stock Market
- Equities
- ENVB Stock
- News Enveric Biosciences, Inc.
- Aegis Capital Downgrades Enveric Biosciences to Hold from Buy, Adjusts Price Target to $0.20 from $7